Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
HBIO

Market Cap: $36.22M

HI

Harvard Bioscience, Inc.

HBIO

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin58.16%

EBITDA Margin-1.07%

EBIT Margin-8.15%

Pre-tax Margin-12.00%

Net Profit Margin-11.86%

Earnings Yield-28.65%

Valuation Multiples

Price / Book4.90

Price / Sales0.41

Price / Earnings-3.45

PEG-0.05

Forward PEG0.01

EV / Sales0.84

EV / EBITDA-78.72

EV / Operating Cash Flow113.90

EV / Free Cash Flow-52.35

Price / Free Cash Flow-25.65

Price / Operating Cash Flow56.00

Cash Flow & Capital

Free Cash Flow / Share-$0.31

Operating Cash Flow / Share$0.14

Free Cash Flow Yield-3.90%

Capex / Revenue2.35%

Capex / Operating Cash Flow3.18%

Capex / Depreciation0.38

Stock Compensation / Revenue1.18%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.87

Quick Ratio0.98

Cash Ratio0.26

Debt / Assets0.58

Debt / Capital0.86

Debt / Equity5.96

Long-Term Debt / Capital0.83

Debt / Market Cap1.01%

Net Debt / EBITDA-40.15

Solvency Ratio-0.06

Financial Leverage10.28

Efficiency & Working Capital

Asset Turnover1.15

Fixed Asset Turnover7.47

Inventory Turnover1.65

Receivables Turnover6.06

Payables Turnover5.90

Days Sales Outstanding60.27

Days Inventory Outstanding220.84

Days Payables Outstanding61.83

Operating Cycle281.12

Cash Conversion Cycle219.28

Working Capital Turnover3.88

Returns & Quality

Return on Equity-92.01%

Return on Assets-13.65%

Return on Invested Capital1.91%

ROCE1.99%

Return on Tangible Assets-17.14%

Operating Return on Assets1.33%

Income Quality-0.06

Tax Burden0.99

Interest Burden1.47

Balance Sheet & Intrinsic Metrics

Enterprise Value$73.92M

Invested Capital$48.97M

Working Capital$21.67M

Tangible Asset Value$-8.13M

Net Current Asset Value$-22.41M

Graham Net-Net-$8.92

Book Value / Share$1.64

Tangible Book Value / Share-$1.8

Cash / Share$1.44

Financial Health Scores

Piotroski Score5

Altman Z-Score-2.55

Revenue$87.81M

EBIT$-7.15M

Market Cap$36.76M

Working Capital$21.67M

Retained Earnings$-221.04M

Total Assets$76.29M

Total Liabilities$68.87M